Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer
By Zhen Zhang, R. Bast, Yin-hua Yu, Jinong Li, L. Sokoll, A. Rai, Jason M. Rosenzweig, Bonnie Cameron, Young Y. Wang, Xiao-Ying Meng and 8 more. Cancer Research, 2004
941 citations recorded by the source corpus.
Subfields: Cancer Research, Reproductive Medicine, Spectroscopy
View Paper: https://www.semanticscholar.org/paper/18fdd4f0561380da5a459a01078cc028801d8d01
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Spectroscopy
- D. Teupser
- L. Holdt
- Philipp E. Geyer
- Matthias Mann
- Jüergen Cox
- Jesper V. Olsen
- Shao-En Ong
- R. Aebersold
Citations in the corpus
- Revisiting biomarker discovery by plasma proteomics (2017, positive): “…is the OVA1 test, in which the levels of the highly abundant plasma proteins beta-2 macroglobulin, apolipoprotein 1, serum transferrin, and pre-albumin were combined with the previously established ovarian cancer marker CA125 in a narrow, FDAapproved indication (Rai et al, 2002; Zhang et al, 2004).”